AMI Pharm’s AYP-101 Shows Strong Phase 2 Results f...
Category : Clinical Trial Update 2 September 2025AMI Pharm’s novel injectable, AYP-101, has delivered promising Phase 2 results in treating sub...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Oslo University Hospital Launches Phase 2 Trial of...
Category : Clinical Trial Update 2 September 2025Oslo University Hospital will initiate a multicentre randomized Phase 2 trial of ILB® in Amyotro...
Merck Shares Mixed Results for Verquvo in Heart Fa...
Category : Clinical Trial Update 1 September 2025Merck, known as MSD outside the US and Canada, announced results from the phase 3 VICTOR trial evalu...
Zydus Therapeutics’ Saroglitazar Hits Phase 3 Mile...
Category : Clinical Trial Update 1 September 2025Zydus Therapeutics, the US arm of Zydus Lifesciences Ltd., has reported positive topline results fro...
Bristol Myers Squibb to Present New Cardiovascular...
Category : Clinical Trial Update 29 August 2025Bristol Myers Squibb (BMS) will showcase new clinical and real-world findings from its cardiovascula...
Latest Newsletter Post
-
Oslo University Hospital Launches P..
2 September 2025
-
AMI Pharm’s AYP-101 Shows Strong Ph..
2 September 2025
-
Zydus Therapeutics’ Saroglitazar Hi..
1 September 2025
-
Merck Shares Mixed Results for Verq..
1 September 2025
-
Correctseq’s CS-101 Marks First Bas..
29 August 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com